Drug price increases: 8 drugs that have jumped the most in price explained

Drug price increases can hit patients hard, especially when a prescription goes from affordable to out of reach with little warning. When people search for drug price increases, they usually want a simple answer: which drugs got more expensive, by how much, and why did it happen? They also want to know whether these price jumps are part of a larger trend in the U.S. pharmaceutical market.

This article breaks down the issue in plain language, highlights eight drugs that have seen some of the steepest price increases, and explains the common reasons behind these jumps. While exact prices can vary by pharmacy, insurance plan, and time period, the examples below reflect widely reported patterns in drug pricing. For a broader look at the market forces behind these changes, see why some drugs cost so much — and others don’t.

Why do drug prices jump so much?

Before looking at the individual drugs, it helps to understand why prescription prices can rise in the first place. Drug price increases usually reflect the market around a medication more than the chemistry inside it.

Drug price increases may happen because of:

• Inflation and manufacturing costs
• Patent protection or limited competition
• Supply shortages
• Market repositioning by manufacturers
• Lack of generic alternatives
• Changes in insurance coverage or rebates
• Consolidation in the pharmacy benefit market

In some cases, the price increase is not tied to a change in the drug itself. Instead, the list price goes up while discounts, rebates, or insurance negotiations happen behind the scenes. That means patients may still feel the increase even if the manufacturer says the net price is different. To understand how coverage and access affect real-world affordability, it also helps to look at FDA drug information and approval resources, which explain how medications move through the system.

8 drugs that have jumped the most in price explained

Here are eight drugs that have become known for dramatic price increases or long-term high-cost trends. The numbers and dates can vary depending on the source, but these drugs are consistently cited in discussions about rising prescription costs. These examples show how drug price increases can affect both everyday medications and specialty treatments.

1. Humira

What it treats: Rheumatoid arthritis, Crohn’s disease, psoriasis, and other autoimmune conditions

Humira is one of the best-known examples of high-cost prescription medicine. For years, it was one of the most expensive and widely used biologic medications in the U.S. The price increased steadily over time, especially before biosimilar competition began entering the market. This is one of the clearest cases of drug price increases becoming a long-running public issue.

Why the price jumped:

• Long market exclusivity
• Strong demand
• Complex biologic manufacturing
• Limited competition for many years

Humira became a symbol of how brand-name specialty drugs can stay expensive for a long time, especially when there are barriers to substitution. For patients following drug price increases, Humira is often the first example that comes to mind.

2. EpiPen

What it treats: Severe allergic reactions, including anaphylaxis

EpiPen became widely discussed after sharp price increases brought public and political attention to the cost of lifesaving medications. The device itself delivers epinephrine, but the device-based delivery system and branding played a major role in its rising cost.

Why the price jumped:

• Market dominance by one product line
• Limited competition in auto-injectors
• Brand pricing strategy
• Consumer dependence on emergency access

For many families, EpiPen’s price rise was especially alarming because it is not a drug people can easily choose to skip. In discussions about drug price increases, EpiPen remains a powerful example of how access and safety can be affected at the same time.

3. Insulin products, including Humalog

What it treats: Diabetes

Insulin is essential for millions of people with diabetes, and some insulin products have seen major price increases over the years. Humalog is one of the most frequently cited examples, though it is not the only insulin affected. Patients comparing options often find that insulin cost differences can be dramatic from one brand or pharmacy to another.

Why the price jumped:

• Complex production and distribution
• Strong market concentration
• Delayed generic-like competition
• Pricing systems involving rebates and formularies

Insulin price increases have been especially controversial because patients with diabetes often need the medication every day. Even modest increases can have a major effect on health and household budgets. If you want a deeper look at this issue, read why insulin is so expensive and what you can do now. Drug price increases are especially painful when the medication is not optional.

4. Revlimid

What it treats: Multiple myeloma and other blood cancers

Revlimid has long been one of the most expensive cancer drugs in the U.S. Its price rose significantly during its period of market exclusivity, making it a major concern for patients and insurers. Among modern drug price increases, Revlimid is often discussed because it combines serious illness, limited alternatives, and a very expensive treatment pathway.

Why the price jumped:

• Patent protection
• High value in treating serious cancers
• Limited alternatives for many patients
• Specialty drug pricing dynamics

Cancer drugs often cost more because they are highly specialized and used in life-threatening situations, but Revlimid stands out because of the scale of its price growth. The broader lesson from drug price increases is that high clinical value does not always translate into high affordability.

5. Daraprim

What it treats: Toxoplasmosis and other parasitic infections

Daraprim became notorious after a dramatic price increase drew national outrage. Though the medication had long been available, its price rose sharply after a company change in ownership. The resulting backlash made Daraprim a defining case in debates about drug price increases.

Why the price jumped:

• Very limited competition
• Small patient population
• Market control over an older drug
• Price-setting freedom in an underserved niche

Daraprim is often cited as a textbook example of how an older medication can become dramatically more expensive when competition is weak. It also shows why drug price increases can happen even when a product itself has been on the market for years.

6. Zolgensma

What it treats: Spinal muscular atrophy

Zolgensma is one of the most expensive drugs ever approved, though its pricing is different from the steady increases seen in many older medications. It is a gene therapy with a very high one-time treatment cost. In discussions of drug price increases, Zolgensma is often used to show how new technology can reset expectations about what a treatment may cost.

Why the price jumped:

• Advanced gene therapy technology
• Potentially life-changing treatment for a rare disease
• High research and development costs
• Extremely limited patient population

Although Zolgensma is not a traditional “price increase” story, it is often included in conversations about drugs that have jumped in price because it represents a dramatic new level of drug cost in the market. It also raises hard questions about how health systems handle one-time treatments priced like major assets.

7. Harvoni

What it treats: Hepatitis C

Harvoni transformed hepatitis C treatment, offering high cure rates with a relatively short course of therapy. But when it was introduced, the price shocked patients, doctors, and insurers. In the context of drug price increases, Harvoni is an example of a breakthrough medicine that arrived with a premium cost.

Why the price jumped:

• Breakthrough effectiveness
• High demand from a large patient population
• Patent protection
• Premium pricing for a curative therapy

Harvoni is a good example of how a highly effective drug can still create affordability problems when the launch price is extremely high. The headline lesson from drug price increases is that better outcomes do not always mean lower bills.

8. Ozempic

What it treats: Type 2 diabetes; also widely used in weight management discussions

Ozempic’s popularity has surged, and so has attention on its price. Even where list price changes are not the only issue, the overall cost to patients has become a major topic because demand has grown so quickly. The rise in attention around Ozempic has made it one of the most talked-about drug price increases in recent years.

Why the price jumped:

• Massive demand
• Supply constraints
• Strong branding and media attention
• Broader off-label interest
• Insurance restrictions in many plans

Ozempic highlights a modern pricing challenge: when demand spikes faster than supply and coverage policies lag behind, access becomes more expensive and more complicated. That is why drug price increases are not always about older monopoly-style pricing; sometimes they are about sudden demand pressure too.

Are these the only drugs with big price increases?

No. Many other medications have seen significant price jumps, especially specialty drugs, brand-name medications without generic competition, and products used for chronic conditions. The eight drugs above are just some of the most widely discussed examples of drug price increases in the public conversation.

Other categories that often experience price increases include:

• Asthma inhalers
• Injectable biologics
• Oncology medications
• Rare disease treatments
• Brand-name medications with few substitutes

Some patients are also affected by products that become harder to source or more expensive to ship, which can make drug price increases feel even sharper at the pharmacy counter.

Why do some old drugs become expensive again?

A common question is why an older drug, sometimes one that has been around for decades, suddenly becomes much more expensive.

The answer usually comes down to market structure, not the drug itself. If only one company makes the product, or if generic competition disappears, prices can rise sharply. In other cases, companies may acquire older drugs and reprice them strategically if the medicine is still medically necessary.

This is why some of the steepest drug price increases happen with drugs that are not new at all. A medication can be old, familiar, and clinically useful while still becoming harder for patients to afford.

That same pattern also shows up in related coverage disputes, where a medication may be available in theory but difficult to access in practice because insurance rules, prior authorization, or pharmacy network changes get in the way. Patients often only notice the problem after a refill suddenly costs much more than expected.

What’s the difference between list price and what patients pay?

This is an important point, because headlines about drug price increases often refer to the list price, not the final amount patients pay.

• List price: The manufacturer’s posted price before discounts
• Net price: The price after rebates and discounts
• Out-of-pocket cost: What the patient pays, depending on insurance

A drug may have a rising list price while insurers negotiate rebates that reduce the net cost. However, patients with high deductibles or limited coverage may still feel the full impact of the increase. That is why drug price increases can be so frustrating: the system is complicated, but the bill is very real.

It is also why two patients can have very different experiences at the same pharmacy. One may have a low copay because of a generous plan, while another pays the full cash price. In practical terms, the number on the bottle is only part of the story.

Why drug price increases matter

Prescription price spikes matter because they can lead to:

• Skipped doses
• Delayed treatment
• Financial stress
• Worsening health outcomes
• Reduced adherence to long-term therapy

For essential medicines like insulin or epinephrine, price increases can become a direct public health issue. For cancer drugs and rare disease treatments, high costs may limit access even when the medication is medically necessary. In other words, drug price increases can affect both survival and quality of life.

These effects are part of a larger debate about affordability. For readers interested in the policy side, why the U.S. struggles to provide healthcare for the poor helps explain why prescription access is such a persistent problem.

There is also a long-term effect that often gets overlooked: when patients delay care because of cost, other parts of the healthcare system may end up paying more later. A missed refill can become an urgent care visit, an emergency room trip, or a hospitalization. So the financial consequences of drug price increases do not stop at the pharmacy counter.

Can patients do anything to lower the cost?

Yes. While not every drug has an easy workaround, patients can often lower costs by:

• Asking for a generic or biosimilar
• Checking multiple pharmacies
• Using manufacturer savings programs
• Reviewing insurance formulary options
• Asking the prescriber about therapeutic alternatives
• Exploring patient assistance programs
• Comparing cash price versus insurance price

For expensive drugs, it can also help to ask the doctor’s office or pharmacist about prior authorizations, appeal options, and specialty pharmacy resources. If a drug price increase has made treatment unaffordable, do not assume there are no options.

In some cases, people can also ask whether a comparable medication may have lower cash pricing, or whether the prescriber can change the dosage form to reduce waste. Those small changes sometimes make a meaningful difference when drug price increases hit a household budget.

It may also help to ask whether the medication is available in a patient assistance program, whether a 90-day supply is cheaper than monthly fills, or whether mail-order pricing is better than local retail pricing. None of these steps solve the larger pricing problem, but they can reduce immediate out-of-pocket pain.

The broader market behind drug price increases

Drug pricing in the U.S. is shaped by a mix of manufacturers, insurers, pharmacy benefit managers, wholesalers, and pharmacy networks. That system can hide the true source of a price jump from patients, which is why drug price increases are so difficult to trace in real time.

A few factors make the system especially complex:

• Manufacturers set list prices
• PBMs negotiate rebates and formulary placement
• Insurers decide coverage and cost-sharing
• Pharmacies dispense the drug and collect payment
• Patients often see only the final amount due

Because of that structure, a drug can appear to become more expensive even when the net economics are more complicated. Still, from the patient’s point of view, drug price increases usually feel straightforward: the prescription costs more than it did before.

The same structure also explains why the conversation about pricing is so often political. Changes in one part of the system can shift costs somewhere else without making the medication more affordable overall. Patients may see a higher deductible bill, a larger copay, or a pharmacy rejection even when a manufacturer’s official pricing change seems small.

How these price spikes affect real people

When people hear about drug price increases, the numbers can sound abstract. But in practice, the effects are deeply personal. A parent may have to choose between paying the bill and refilling a child’s emergency allergy medication. A person with diabetes may ration insulin. A cancer patient may delay treatment while waiting for prior authorization or financial assistance.

That is why discussions about drug price increases should always keep the patient experience in view. Price is not just a number on a receipt; it can shape whether someone gets treated on time, follows a care plan, or even stays out of the hospital.

For some families, the stress begins before the prescription is even filled. They may call around to compare prices, ask for partial fills, or wait to see whether insurance approves the medication. When the answer is no, the medical issue becomes a financial emergency too.

And even when a patient manages to pay, the pressure can continue month after month. Repeated high costs can lead to skipped follow-up visits, reduced adherence, or difficult decisions about other household expenses. That is why price spikes are not just a pharmacy issue — they are a real-world access issue.

The bottom line

The eight drugs most often associated with major price jumps show the same pattern: when competition is limited and demand is high, prices can rise fast. Some of these medications are essential for chronic conditions, while others are breakthrough treatments for rare or serious diseases. In every case, the result is the same for many patients: higher costs and more difficulty accessing care.

Understanding which drugs have jumped the most in price, and why, helps explain a bigger problem in the U.S. healthcare system. Drug pricing is not just about one medication or one company. It reflects how patents, market power, manufacturing, demand, and insurance all interact to shape what patients pay at the pharmacy. The more clearly we understand drug price increases, the easier it becomes to ask better questions and find better solutions.

For patients, the most practical takeaway is simple: compare options, ask questions, and do not assume the first quoted price is the only price available. Even in a system with rising costs, there are sometimes ways to reduce the immediate burden while the broader pricing debate continues.